Xenon for NMR biosensing - Inert but alert

Physica Medica

Volumn 29, Issue 1, 2013, Pages 3-16

  Schröder, Leif ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Biosensor; CEST; Contrast agent; Hyperpolarization; MRI; NMR; SEOP; Xenon

Indexed keywords

ARGININE; CARBONATE DEHYDRATASE II; CRYPTOPHANE; DENDRIMER; INERT GAS; INTEGRIN; LIQUID NITROGEN; MATRILYSIN; MOLECULAR MARKER; POLYCATION; PROTON; RADIOISOTOPE; UNCLASSIFIED DRUG; XENON; XENON 129;

BINDING KINETICS; BIOSENSOR; BIOTINYLATION; CELL MEMBRANE TRANSPORT; CHEMICAL EXCHANGE SATURATION TRANSFER; CHEMICAL INTERACTION; CHEMICAL PARAMETERS; CHEMICAL STRUCTURE; DEFENSE MECHANISM; DNA HYBRIDIZATION; DRUG UPTAKE; ENZYME SPECIFICITY; EQUIPMENT DESIGN; GENETIC PROCEDURES; HYDROPHOBICITY; HYPERPOLARIZATION; INTERMETHOD COMPARISON; MAGNETISM; MICROENVIRONMENT; NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; SOLUBILITY; SPIN POLARIZATION; STATIC ELECTRICITY; TEMPERATURE; VIRUS CAPSID;

ANIMALS; BIOLOGICAL TRANSPORT; BIOSENSING TECHNIQUES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PHYSICOCHEMICAL PROCESSES; XENON;

EID: 84871801312     PISSN: 11201797     EISSN: 1724191X     Source Type: Journal    
DOI: 10.1016/j.ejmp.2011.11.001     Document Type: Review

References (100)

1. Emsley J.W., Feeney J. Forty years of progress in nuclear magnetic resonance spectroscopy. Progr NMR Spectrosc 2007, 50:179-198.
2. Modern magnetic resonance 2006, vol. I-II. Springer, Dordrecht, The Netherlands. G.A. Webb (Ed.).
3. Weissleder R., Mahmood U. Molecular imaging. Radiology 2001, 219(2):316-333.
4. Massoud T.F., Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003, 17(5):545-580.
5. Sosnovik D.E., Weissleder R. Emerging concepts in molecular MRI. Curr Opin Biotechnol 2007, 18(1):4-10.
6. Aime S., Dastrù W., Gobetto R., Santelia D., Viale A. Agents for polarization enhancement in MRI. Handb Exp Pharmacol 2008, 185(Pt 1):247-272.
7. Viale A., Reineri F., Santelia D., Cerutti E., Ellena S., Gobetto R., et al. Hyperpolarized agents for advanced MRI investigations. Q J Nucl Med Mol Imaging 2009, 53(6):604-617.
8. Goodson B.M. Nuclear magnetic resonance of laser-polarized noble gases in molecules, materials, and organisms. J Magn Reson 2002, 155(2):157-216.
9. Cherubini A., Bifone A. Hyperpolarised xenon in biology. Progr NMR Spectrosc 2003, 42:1-30.
10. Oros A.M., Shah N.J. Hyperpolarized xenon in NMR and MRI. Phys Med Biol 2004, 49(20):R105-R153.
11. Driehuys Hedlund L.W. Imaging techniques for small animal models of pulmonary disease: MR microscopy. Toxicol Pathol 2007, 35:49-58.
12. Spence M.M., Rubin S.M., Dimitrov I.E., Ruiz E.J., Wemmer D.E., Pines A., et al. Functionalized xenon as a biosensor. Proc Natl Acad Sci USA 2001, 98:10654-10657.
13. Clever H.L. Solubility data series 1979, Pergamon Press, New York.
14. Walker T.G., Happer W. Spin-exchange optical pumping of noble-gas nuclei. Rev Mod Phys 1997, 69:629-642.
15. Mastromarino P.A., Otey C.R., Pripstein D., Hughes E.W. Tunable diode laser study of pressure broadening of Rb D1 lines in the presence of 4He buffer gas. Nucl Instr Meth Phys Res Sect B Beam Interactions Mater Atoms 2002, 194(1):69-77.
16. Volodin B.L., Dolgy S.V., Melnik E.D., Downs E., Shaw J., Ban V. Wavelength stabilization and spectrum narrowing of high-power multimode laser diodes and arrays by use of volume Bragg gratings. Opt Lett 2004, 29:1891-1893.
17. Nikolaou P., Whiting N., Eschmann N.A., Chaffee K.E., Goodson B.M., Barlow M.J. Generation of laser-polarized xenon using fiber-coupled laser-diode arrays narrowed with integrated volume holographic gratings. J Magn Reson 2009, 197:249-254.
18. 129Xe spin-exchange optical pumping using VHG-narrowed laser diode arrays. J Magn Reson 2011, 208(2):298-304.
19. 129Xe: a theoretical study. Appl Phys B 2007, 89:65-71.
20. Walter D.K., Griffith W.M., Happer W. Energy transport in high-density spin-exchange optical pumping cells. Phys Rev Lett 2001, 86:3264-3267.
21. Berthault P., Huber G., Desvaux H. Biosensing using laser-polarized xenon NMR/MRI. Progr NMR Spectrosc 2009, 55:35-60.
22. Zook A.L., Adhyaru B.B., Bowers C.R. High capacity production of >65% spin polarized xenon-129 for NMR spectroscopy and imaging. J Magn Reson 2002, 159(2):175-182.
23. Ruset I.C., Ketel S., Hersman F.W. Optical pumping system design for large production of hyperpolarized xenon. Phys Rev Lett 2006, 96(5):053002.
24. 129Xe to solutions. Anal Chem 2005, 77:4008-4012.
25. Hilty C., Lowery T.J., Wemmer D.E., Pines A. Spectrally resolved magnetic resonance imaging of a xenon biosensor. Angew Chem Intl Ed 2006, 45:70-73.
26. 129Xe using a membrane-based continuous flow system. J Magn Reson 2009, 201:93-99.
27. 3-subunit. J Chem Soc Chem Commun 1981, 1137-1139.
28. Brotin T., Dutasta J.P. Cryptophanes and their complexes. Present and future. Chem Rev 2009, 109:88-130.
29. Holman K.T. Cryptophanes: molecular containers. Encyclopedia of supramolecular chemistry 2004, 340-348. CRC Press. J.L. Atwod, J.W. Steed (Eds.).
30. Spence M.M., Ruiz E.J., Rubin S.M., Lowery T.J., Winssinger N., Schultz P.G., et al. Development of a fnctionalized xenon biosensor. J Am Chem Soc 2004, 126:15287-15294.
31. 1H NMR study of the reversible trapping of xenon by cryptophane-A in organic solution. J Am Chem Soc 1998, 120:784-791.
32. 129Xe NMR of the consequences of size of the host cavity for xenon encapsulation. Eur J Org Chem 2003, 973-984.
33. Huber G., Beguin L., Desvaux H., Brotin T., Fogarty H.A., Dutasta J.P., et al. Cryptophane-xenon complexes in organic solvents observed through NMR spectroscopy. J Phys Chem A 2008, 112:11363-11372.
34. Fairchild R.M., Joseph A.I., Holman K.T., Fogarty H.A., Brotin T., Dutasta J.P., et al. A water-soluble Xe@cryptophane-111 complex exhibits very high thermodynamic stability and a peculiar (129)Xe NMR chemical shift. J Am Chem Soc 2010, 132(44):15505-15507.
35. Kotera N., Delacour L., Traorér T., Tassali N., Berthault P., Buisson D.A., et al. Design and synthesis of new cryptophanes with intermediate cavity Sizes. Org Lett 2011, 13(9):2153-2155.
36. Taratula O., Hill P.A., Khan N.S., Carroll P.J., Dmochowski I.J. Crystallographic observation of 'induced fit' in a cryptophane host-guest model system. Nat Commun 2010, 1:148.
37. Fogarty H.A., Berthault P., Brotin T., Huber G., Desvaux H., Dutasta J.P. A cryptophane core optimized for xenon encapsulation. J Am Chem Soc 2007, 129:10332-10333.
38. Huber G., Brotin T., Dubois L., Desvaux H., Dutasta J.P., Berthault P. Water soluble cryptophanes showing unprecedented affinity for xenon: candidates as NMR-based biosensors. J Am Chem Soc 2006, 128:6239-6246.
39. Hill P.A., Wei Q., Troxler T., Dmochowski I.J. Substituent effects on xenon binding affinity and solution behavior of water-soluble cryptophanes. J Am Chem Soc 2009, 131:3069-3077.
40. Jacobson D.R., Khan N.S., Collé R., Fitzgerald R., Laureano-Pérez L., Bai Y., et al. Measurement of radon and xenon binding to a cryptophane molecular host. Proc Natl Acad Sci USA 2011, 108(27):10969-10973.
41. Hill P.A., Wei Q., Eckenhoff R.G., Dmochowski I.J. Thermodynamics of xenon binding to cryptophane in water and human plasma. J Am Chem Soc 2007, 129(30):9262-9263.
42. Chaffee K.E., Fogarty H.A., Brotin T., Goodson B.M., Dutasta J.P. Encapsulation of small gas molecules by cryptophane-111 in organic solution. 1. Size- and shape-selective complexation of simple hydrocarbons. J Phys Chem A 2009, 113(49):13675-13684.
43. 129Xe biosensors. J Am Chem Soc 2008, 130:16456-16457.
44. 129Xe NMR-based biosensors. Chem Commun 2008, 2756-2758.
45. Huber G., Legrand F.X., Lewin V., Baumann D., Heck M.P., Berthault P. Interaction of xenon with Cucurbit[5]uril in water. Chemphyschem 2011, 12(6):1053-1055.
46. Lerouge F., Melnyk O., Durand J.O., Raehm L., Berthault P., Huber G., et al. Towards thrombosis-targeted zeolite nanoparticles for laser-polarized Xe-129 MRI. J Mater Chem 2009, 19:379-386.
47. Wei Q., Seward G.K., Hill P.A., Patton B., Dimitrov I.E., Kuzma N.N., et al. Designing Xe-129 NMR biosensors for matrix metalloproteinase detection. J Am Chem Soc 2006, 128:13274-13283.
48. Chambers J.M., Hill P.A., Aaron J.A., Han Z.H., Christianson D.W., Kuzma N.N., et al. Cryptophane xenon-129 nuclear magnetic resonance biosensors targeting human carbonic anhydrase. J Am Chem Soc 2009, 131:563-569.
49. Boutin C., Stopin A., Lenda F., Brotin T., Dutasta J.P., Jamin N., et al. Cell uptake of a biosensor detected by hyperpolarized (129)Xe NMR: the transferrin case. Bioorg Med Chem 2011, 19(13):4135-4143.
50. Seward G.K., Wei Q., Dmochowski I.J. Peptide-mediated cellular uptake of cryptophane. Bioconj Chem 2008, 19:2129-2135.
51. Roy V., Brotin T., Dutasta J.-P., Charles M.-H., Delair T., Mallet F., et al. A cryptophane biosensor for the detection of specific nucleotide targets through xenon NMR spectroscopy. ChemPhysChem 2007, 8:2082-2085.
52. Schlundt A., Kilian W., Beyermann M., Sticht J., Günther S., Höpner S., et al. A xenon-129 biosensor for monitoring MHC-peptide interactions. Angew Chem Int Ed Engl 2009, 48:4142-4145.
53. 129Xe-cryptophane biosensor complexed with human carbonic anhydrase II. J Am Chem Soc 2008, 130:6942-6943.
54. Lowery T.J., Garcia S., Chavez L., Ruiz E.J., Wu T., Brotin T., et al. Optimization of xenon biosensors for detection of protein interactions. ChemBioChem 2006, 7:65-73.
55. Aime A., Delli Castelli D., Geniatti Crich S., Gianolo E., Terreno E. Pushing the sensitivity envelope of lanthanide based magnetic resonance imaging (MRI) contrast agent for molecular imaging applications. Acc Chem Res 2009, 42:822-831.
56. Mynar J.L., Lowery T.J., Wemmer D.E., Pines A., Fréchet J.M.J. Xenon biosensor amplification via dendrimer-cage supramolecular constructs. J Am Chem Soc 2006, 128:6334-6335.
57. Ruiz E.J., Sears D.N., Pines A., Jameson C.J. Diastereomeric Xe chemical shifts in tethered cryptophane cages. J Am Chem Soc 2006, 128:16980-16988.
58. Hooker J.M., Datta A., Raymond K.N., Francis M.B. Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. Nano Lett 2007, 7:2207-2210.
59. Datta A., Hooker J.M., Botta M., Francis M.B., Aime S., Raymond K.N. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents. J Am Chem Soc 2008, 130:2546-2552.
60. Meldrum T., Seim K.L., Bajaj V.S., Palaniappan K.K., Wu W., Francis M.B., et al. A xenon-based molecular sensor assembled on an MS2 viral capsid scaffold. J Am Chem Soc 2010, 132:5936-5937.
61. Tong G.J., Hsiao S.C., Carrico Z.M., Francis M.B. Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. J Am Chem Soc 2009, 131:11174-11178.
62. Bowers C.R., Weitekamp D.P. Transformation of symmetrization order to nuclear-spin magnetization by chemical reaction and nuclear magnetic resonance. Phys Rev Lett 1986, 57:2645-2648.
63. Adams R.W., Aguilar J.A., Atkinson K.D., Cowley M.J., Elliott P.I.P., Duckett S.B., et al. Reversible interactions with para-hydrogen enhance NMR sensitivity by polarization transfer. Science 2009, 323:1708-1711.
64. Ardenkjaer-Larsen J.H., Fridlund B., Gram A., Hansson G., Hansson L., Lerche M.H., et al. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci USA 2003, 100(18):10158-10163.
65. Seward G.K., Bai Y., Khan N.S., Dmochowski I.J. Cell-compatible, integrin-targeted cryptophane-129Xe NMR biosensors. Chem Sci 2011, 2:1103-1110.
66. Gupta B., Levchenko T.S., Torchilin V.P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev 2005, 57:637-651.
67. Goun E.A., Shinde R., Dehnert K.W., Adams-Bond A., Wender P.A., Contag C.H., et al. Intracellular cargo delivery by an octaarginine transporter adapted to target prostate cancer cells through surface protease activation. Bioconj Chem 2006, 17:787-796.
68. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000, 18:410-414.
69. Cairns R.A., Khokha R., Hill R.P. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 2003, 3:659-671.
70. Ye Y.P., Bloch S., Xu B.G., Achilefu S. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J Med Chem 2006, 49:2268-2275.
71. 129Xe NMR signature of living biological cells. NMR Biomed 2011.
72. Möller H.E., Chen X.J., Saam B., Hagspiel K.D., Johnson G.A., Altes T.A., et al. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 2002, 47:1029-1051.
73. 129Xe in human brain analyzed by a uptake model. Magn Reson Med 2004, 51:843-847.
74. Schröder L., Chavez L., Meldrum T., Smith M., Lowery T.J., Wemmer D.E., et al. Temperature-controlled molecular depolarization gates in nuclear magnetic resonance. Angew Chem Int Ed 2008, 47:4316-4320.
75. Ward K.M., Aletras A.H., Balaban R.S. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000, 143:79-87.
76. Moulé A.J., Spence M.M., Han S., Seeley J.A., Pierce K.L., Saxena S., et al. Amplification of xenon NMR and MRI by remote detection. Proc Natl Acad Si USA 2003, 100:9122-9127.
77. Harel E., Schröder L., Xu S. Novel detection schemes of nuclear magnetic resonance imaging: application from analytical chemistry to molecular sensors. Annu Rev Anal Chem 2008, 1:133-163.
78. Grad J., Bryant R.G. Nuclear magnetic cross-relaxation spectroscopy. J Magn Reson 1990, 90:1-8.
79. Harel E., Hilty C., Koen K., McDonnell E., Pines A. Time-of-flight flow imaging of two-component flow inside a microfluidic chip. Phys Rev Let 2007, 98(1):017601.
80. Garcia S., Chavez L., Lowery T.J., Han S., Wemmer D.E., Pines A. Sensitivity enhancement by exchange mediated magnetization transfer of the xenon biosensor signal. J Magn Reson 2007, 184:72-77.
81. Friedman J.I., McMahon M.T., Stivers J.T., van Zijl P.C.M. Indirect detection of labile solute proton spectra via the water signal using frequency-labeled exchange (FLEX) transfer. J Am Chem Soc 2010, 132:1813-1815.
82. Schröder L., Lowery T.J., Hilty C., Wemmer D.E., Pines A. Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor. Science 2006, 314:446-449.
83. Sherry A.D., Woods M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng 2008, 10:391-411.
84. De Leon-Rodriguez L.M., Lubag A.J., Malloy C.R., Martinez G.V., Gillies R.J., Sherry A.D. Responsive MRI agents for sensing metabolism in vivo. Acc Chem Res 2009, 42(7):948-957.
85. Hancu I., Dixon W.T., Woods M., Vinogradov E., Sherry A.D., Lenkinski R.E. CEST and PARACEST MR contrast agents. Acta Radiol 2010, 51(8):910-923.
86. Ruppert K., Brookeman J.R., Hagspiel K.D., Mugler J.P. Probing lung physiology with xenon polarization transfer contrast (XTC). Magn Reson Med 2000, 44:349-357.
87. 129Xe depolarization transfer and its application for ultra-sensitive NMR detection. Phys Rev Lett 2008, 100:257603.
88. Goffeney N., Bulte J.W., Duyn J., Bryant L.H., van Zijl P.C. Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. J Am Chem Soc 2001, 123:8628-8629.
89. Snoussi K., Bulte J.W., Guéron M., van Zijl P.C.M. Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med 2003, 49:998-1005.
90. Aime S., Delli Castelli D., Terreno E. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. Angew Chem Int Ed 2005, 44:5513-5515.
91. Sun P.Z., van Zijl P.C.M., Zhou J. Optimization of the irradiation power in chemical exchange dependent saturation transfer experiments. J Magn Reson 2005, 175:193-200.
92. McMahon M.T., Gilad A.A., Zhou J., Sun P.Z., Bulte J.W., van Zijl P.C. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP): Ph calibration for poly-L-lysine and a starburst dendrimer. Magn Reson Med 2006, 55:836-847.
93. Zhang S., Winter P., Wu K., Sherry D.K. A novel europium(III)-based MRI contrast agent. J Am Chem Soc 2001, 123:1517-1518.
94. Aime S., Carrera C., Delli Castelli D., Geniatti Crich S., Terreno E. Tunable imaging of cells labeled with MRI-PARACEST agents. Angew Chem Int Ed 2005, 44:1813-1815.
95. Zhang S., Merritt M., Woessner D.E., Lenkinski R.E., Sherry D.A. PARACEST agents: modulating MRI contrast via water proton exchange. Acc Chem Res 2003, 36:783-790.
96. Meldrum T., Bajaj V.S., Wemmer D.E., Pines A. Band-selective chemical exchange saturation transfer imaging with hyperpolarized xenon-based molecular sensors. J Magn Reson 2011, 10.1016/j.jmr.2011.06.027.
97. Zhou X., Graziani D., Pines A. Hyperpolarized xenon NMR and MRI signal amplification by gas extraction. Proc Natl Acad Sci USA 2009, 106(40):16903-16906.
98. Berthault P., Desvaux H., Wendlinger T., Gyejacquot M., Stopin A., Brotin T., et al. Effect of pH and counterions on the encapsulation properties of xenon in water-soluble cryptophanes. Chemistry 2010, 16(43):12941-12946.
99. Schilling F., Schröder L., Palaniappan K.K., Zapf S., Wemmer D.E., Pines A. MRI thermometry based on encapsulated hyperpolarized xenon. ChemPhysChem 2010, 11(16):3529-3533.
100. Meldrum T., Schröder L., Dener P., Wemmer D.E., Pines A. Xenon-based molecular sensors in lipid suspensions. J Magn Reson 2010, 205:242-246.